Cargando…
DHX37 Is a Promising Prognostic Biomarker and a Therapeutic Target for Immunotherapy and Chemotherapy in HCC
SIMPLE SUMMARY: The DEAD/H-box RNA helicase family is widely involved in tumor progression. Previously, many studies have found that DHX9, DHX15, DDX24, DHX29, etc. are widely involved in tumor progression through various pathways, however, the role of DHX37, as an important member of the DEAD/H-box...
Autores principales: | Liu, Nanbin, Zhang, Hailong, Zhang, Chunli, Li, Zeyu, Huang, Limin, Sun, Jin, Qi, Junan, Deng, Xi, Huang, Na, Mu, Yanhua, Li, Zongfang, Tian, Hongwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648173/ https://www.ncbi.nlm.nih.gov/pubmed/37958405 http://dx.doi.org/10.3390/cancers15215228 |
Ejemplares similares
-
Integrative Expression and Prognosis Analysis of DHX37 in Human Cancers by Data Mining
por: Huang, Kang, et al.
Publicado: (2021) -
Phosphorylation of UHRF2 affects malignant phenotypes of HCC and HBV replication by blocking DHX9 ubiquitylation
por: Wu, Kejia, et al.
Publicado: (2023) -
DHX37 Impacts Prognosis of Hepatocellular Carcinoma and Lung Adenocarcinoma through Immune Infiltration
por: Xu, Yanni, et al.
Publicado: (2020) -
Molecular mechanism of the RNA helicase DHX37 and its activation by UTP14A in ribosome biogenesis
por: Boneberg, Franziska M., et al.
Publicado: (2019) -
DHX37 and NR5A1 Variants Identified in Patients with 46,XY Partial Gonadal Dysgenesis
por: de Oliveira, Felipe Rodrigues, et al.
Publicado: (2023)